Quantcast

Latest Cancer vaccine Stories

2014-07-01 11:10:06

American Association for Cancer Research A new approach demonstrated that the recognition of unique cancer mutations appeared to be responsible for complete cancer regressions in two metastatic melanoma patients treated with a type of immunotherapy called adoptive T-cell therapy. This new approach may help develop more effective cancer immunotherapies, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research. "This study...

2014-07-01 08:31:10

- Triggered by ongoing and very successful multi-year collaboration TUBINGEN, Germany, July 1, 2014 /PRNewswire/ -- CureVac, a German clinical-stage biopharmaceutical company, today announced the execution of an exclusive license agreement with Sanofi Pasteur S.A., the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), to develop and commercialize an mRNA-based vaccine against an undisclosed pathogen. In 2011, CureVac and Sanofi Pasteur signed a collaboration and license...

2014-06-30 12:29:20

Immune Checkpoint Inhibitors Will Hold an Impressive 85 Percent Market Share, According to Findings from Decision Resources Group BURLINGTON, Mass., June 30, 2014 /PRNewswire/ -- Decision Resources Group finds that the immunotherapy market will experience considerable growth through 2022, increasing from $1.1 billion in 2012 to nearly $9 billion in 2022 (corresponding to 23.8 percent annual growth) in the United States, France, Germany, Italy, Spain, United Kingdom and Japan. This impressive...

2014-06-27 14:56:01

German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) A clinical phase I trial to examine the safety of the vaccine against gliomas based on mutant IDH1 in human patients is planned Astrocytomas and oligodendrogliomas are subtypes of a brain cancer called 'glioma'. These incurable brain tumors arise from glial cells, a type of support cell found in the central nervous system. "Low-grade gliomas", which grow comparatively slowly, spread in a diffuse manner across the...

2014-06-25 23:17:06

Immunitor Inc., reported that company’s first proof-of-concept clinical study of its candidate cancer vaccine in patients with terminal stage of liver cancer has been presented at the immunology conference in Mongolia. Vancouver, British Columbia (PRWEB) June 25, 2014 Immunitor Inc., a Vancouver-based biopharmaceutical company engaged in the discovery and development of oral vaccines, announced today that initial clinical data of the company's lead cancer vaccine has been presented...

2014-06-25 08:31:22

LONDON, June 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Triple Analysis: Melanoma, Angiogenesis and Cancer Vaccineshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/triple_analysis_melanoma_angiogenesis_cancer_vaccines.html This triple analysis focuses on cancer drug development strategies in Melanoma and by the two mechanism/target/effect areas of Angiogenesis and Cancer Vaccines. Each of these three individual parts is evaluated...

2014-06-25 08:31:19

LONDON, June 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Triple Analysis: Colorectal Cancer, Melanoma and Cancer Vaccineshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/triple_analysis_colorectal_cancer_melanoma_cancer_vaccines.html This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Melanoma and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual parts is...

2014-06-25 08:31:17

LONDON, June 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Triple Analysis: Leukemia, Melanoma and Cancer Vaccineshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/triple_analysis_leukemia_melanoma_cancer_vaccines.html This triple analysis focuses on cancer drug development strategies in both Leukemia and Melanoma and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual parts is evaluated according to...

2014-06-25 08:31:13

LONDON, June 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Triple Analysis: Lymphoma, Melanoma and Cancer Vaccineshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/triple_analysis_lymphoma_melanoma_cancer_vaccines.html This triple analysis focuses on cancer drug development strategies in both Lymphoma and Melanoma and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual parts is evaluated according to...

2014-06-25 08:31:10

LONDON, June 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Triple Analysis: Lung Cancer, Melanoma and Cancer Vaccineshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/triple_analysis_lung_cancer_melanoma_cancer_vaccines.html This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Melanoma and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual parts is evaluated according to...


Word of the Day
cock-a-hoop
  • Exultant; jubilant; triumphant; on the high horse.
  • Tipsy; slightly intoxicated.
This word may come from the phrase 'to set cock on hoop,' or 'to drink festively.' Its origin otherwise is unclear. A theory, according to the Word Detective, is that it's a 'transliteration of the French phrase 'coq a huppe,' meaning a rooster displaying its crest ('huppe') in a pose of proud defiance.' Therefore, 'cock-a-hoop' would 'liken a drunken man to a boastful and aggressive rooster.'
Related